Search by Drug Name or NDC
NDC 61958-3001-02 Sunlenca 300 mg/1 Details
Sunlenca 300 mg/1
Sunlenca is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Gilead Sciences. The primary component is LENACAPAVIR SODIUM.
Product Information
| NDC | 61958-3001 |
|---|---|
| Product ID | 61958-3001_bd4fa706-84af-4011-a69d-663fc0a3bf6b |
| Associated GPIs | |
| GCN Sequence Number | 084228 |
| GCN Sequence Number Description | lenacapavir sodium TABLET 300 MG ORAL |
| HIC3 | W0N |
| HIC3 Description | ANTIRETROVIRAL - CAPSID INHIBITORS |
| GCN | 53434 |
| HICL Sequence Number | 048555 |
| HICL Sequence Number Description | LENACAPAVIR SODIUM |
| Brand/Generic | Brand |
| Proprietary Name | Sunlenca |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | LENACAPAVIR SODIUM |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 300 |
| Active Ingredient Units | mg/1 |
| Substance Name | LENACAPAVIR SODIUM |
| Labeler Name | Gilead Sciences |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA215974 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 61958-3001-02 (61958300102)
| NDC Package Code | 61958-3001-2 |
|---|---|
| Billing NDC | 61958300102 |
| Package | 1 POUCH in 1 CARTON (61958-3001-2) / 1 BLISTER PACK in 1 POUCH / 5 TABLET, FILM COATED in 1 BLISTER PACK |
| Marketing Start Date | 2022-12-22 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |